Search | Page 40 | Aplastic Anemia and MDS International Foundation


Search results

  1. Casey O’Connell, MD

    ... University of Southern California (USC). In addition to her clinical work with patients at the Norris Comprehensive Cancer Center, she conducts clinical and translational research in Myeloproliferative and Myelodysplastic Syndromes (MDS). She ...

    Page last updated 04/18/2012 - 1:47pm.

  2. Treating Higher-Risk Myelodysplastic Syndromes

    ... would be the hypomethlating agents mentioned earlier. Clinical trials are also an important component to patient care if there is ... decitabine, or lenalidomide (Revlimid®). Clinical research with new chemotherapy combinations are the key to improving therapy ...

    Interview last updated 05/18/2012 - 1:55pm.

  3. Agent Orange, United States Military Veterans, and Myelodysplastic Syndromes

    ... of Medicine at Harvard Medical School. His primary area of research focuses on myelodysplastic syndromes and related conditions.  Dr. ... danger and the severity of MDS are not debated in the clinical medical community, and to call MDS anything less than a group of ...

    Page last updated 12/19/2013 - 10:58am.

  4. Newly Diagnosed

    ... in your personal life and affairs, or about the medical and clinical treatment you receive, newly-diagnosed patients help themselves by ... and other resources. From activity and progress in the research related to bone marrow failure disease all the way through living well ...

    Page last updated 10/25/2012 - 11:32am.